Načítá se...

Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies

Peripheral T-cell lymphomas (PTCLS) comprise a diverse group of difficult to treat, very aggressive non-Hodgkin's lymphomas (NHLS) with poor prognoses and dismal patient outlook. Despite the fact that PTCLs comprise the majority of T-cell malignancies, the standard of care is poorly established...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Chen, Kevin H., Wada, Masayuki, Firor, Amelia E., Pinz, Kevin G., Jares, Alexander, Liu, Hua, Salman, Huda, Golightly, Marc, Lan, Fengshuo, Jiang, Xun, Ma, Yupo
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5302909/
https://ncbi.nlm.nih.gov/pubmed/27494836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11019
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!